| Guardian Hospice Of Oklahoma 1055 North Service Road, Calera, OK, 74730 | |
| (580) 434-6336 |
News Archive
This post in KPLU's "Humanosphere" blog examines the "gap between the disease burden of mental illness and the amount of funding and attention devoted to solving the problem," referencing a post published Friday in the Global Health Interest Forum's "Blog of Scientists for Global Health," written by Paul Southworth, a visiting scholar on malaria and vaccine science at the NIH.
Frontiers is dedicating part of its open science platform infrastructure to collect and disseminate information relevant to the research communities battling the COVID-19 pandemic using its Coronavirus Knowledge Hub.
EarlySense announced today that its EverOn Touch system has been cleared for marketing by the U.S. Food and Drug Administration. The FDA clearance covers several key additions to the traditional EverOn contact-free patient supervision system value proposition. For the first time, the EverOn system includes an online display that alerts medical staff regarding a patient's motion level and verifies patient turns as indicated by nurses. Identifying low patient movement and then turning patients methodically are key elements in the prevention of pressure ulcers, the most costly patient safety risk in U.S. hospitals.
Akeso Medical Imaging BV, announces today the start of a clinical study with their novel imaging device for assessment of joint inflammation in patient with rheumatoid arthritis (RA). In this proof of concept study, Akeso's imaging device will be compared to other methods to assess disease status, such as the DAS-28 score, Ultrasound and in some cases MRI. The study will be performed at the University Medical Center Utrecht (UMC Utrecht) in cooperation with Regional Rheumatology Centre Eindhoven (RRC). Seventy subjects will be included; sixty RA patients with varying degrees of inflammation of the joints of hands and wrists at the time of examination and a control group of ten subjects.
HealthYes!®, a leading preventive medical screening company, is bringing its life-saving mobile screening services to Oklahoma. Leveraging the most medically advanced, state-of-the-art equipment and techniques in the industry, HealthYes! screens its clients for life-threatening medical conditions and diseases including: heart disease, stroke, abdominal aortic aneurysm, peripheral artery disease, diabetes and liver disease along with osteoporosis.
› Verified 7 days ago
| Name | Guardian Hospice Of Oklahoma |
|---|---|
| Location | 1055 North Service Road, Calera, Oklahoma |
| Hospice ID | 371712 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Other |
| Profit Type | FOR PROFIT |
| Accreditation Provider | Community Health Accreditation Partner (CHAP) |
| SSA county code | 060 |
News Archive
This post in KPLU's "Humanosphere" blog examines the "gap between the disease burden of mental illness and the amount of funding and attention devoted to solving the problem," referencing a post published Friday in the Global Health Interest Forum's "Blog of Scientists for Global Health," written by Paul Southworth, a visiting scholar on malaria and vaccine science at the NIH.
Frontiers is dedicating part of its open science platform infrastructure to collect and disseminate information relevant to the research communities battling the COVID-19 pandemic using its Coronavirus Knowledge Hub.
EarlySense announced today that its EverOn Touch system has been cleared for marketing by the U.S. Food and Drug Administration. The FDA clearance covers several key additions to the traditional EverOn contact-free patient supervision system value proposition. For the first time, the EverOn system includes an online display that alerts medical staff regarding a patient's motion level and verifies patient turns as indicated by nurses. Identifying low patient movement and then turning patients methodically are key elements in the prevention of pressure ulcers, the most costly patient safety risk in U.S. hospitals.
Akeso Medical Imaging BV, announces today the start of a clinical study with their novel imaging device for assessment of joint inflammation in patient with rheumatoid arthritis (RA). In this proof of concept study, Akeso's imaging device will be compared to other methods to assess disease status, such as the DAS-28 score, Ultrasound and in some cases MRI. The study will be performed at the University Medical Center Utrecht (UMC Utrecht) in cooperation with Regional Rheumatology Centre Eindhoven (RRC). Seventy subjects will be included; sixty RA patients with varying degrees of inflammation of the joints of hands and wrists at the time of examination and a control group of ten subjects.
HealthYes!®, a leading preventive medical screening company, is bringing its life-saving mobile screening services to Oklahoma. Leveraging the most medically advanced, state-of-the-art equipment and techniques in the industry, HealthYes! screens its clients for life-threatening medical conditions and diseases including: heart disease, stroke, abdominal aortic aneurysm, peripheral artery disease, diabetes and liver disease along with osteoporosis.
› Verified 7 days ago
| NPI Number | 1467876219 |
| Organization Name | Lisa Johns Llc |
| Address | 1055 N Service Rd Calera, Oklahoma, 74730 |
| Phone Number | (580)434-6336 |
News Archive
This post in KPLU's "Humanosphere" blog examines the "gap between the disease burden of mental illness and the amount of funding and attention devoted to solving the problem," referencing a post published Friday in the Global Health Interest Forum's "Blog of Scientists for Global Health," written by Paul Southworth, a visiting scholar on malaria and vaccine science at the NIH.
Frontiers is dedicating part of its open science platform infrastructure to collect and disseminate information relevant to the research communities battling the COVID-19 pandemic using its Coronavirus Knowledge Hub.
EarlySense announced today that its EverOn Touch system has been cleared for marketing by the U.S. Food and Drug Administration. The FDA clearance covers several key additions to the traditional EverOn contact-free patient supervision system value proposition. For the first time, the EverOn system includes an online display that alerts medical staff regarding a patient's motion level and verifies patient turns as indicated by nurses. Identifying low patient movement and then turning patients methodically are key elements in the prevention of pressure ulcers, the most costly patient safety risk in U.S. hospitals.
Akeso Medical Imaging BV, announces today the start of a clinical study with their novel imaging device for assessment of joint inflammation in patient with rheumatoid arthritis (RA). In this proof of concept study, Akeso's imaging device will be compared to other methods to assess disease status, such as the DAS-28 score, Ultrasound and in some cases MRI. The study will be performed at the University Medical Center Utrecht (UMC Utrecht) in cooperation with Regional Rheumatology Centre Eindhoven (RRC). Seventy subjects will be included; sixty RA patients with varying degrees of inflammation of the joints of hands and wrists at the time of examination and a control group of ten subjects.
HealthYes!®, a leading preventive medical screening company, is bringing its life-saving mobile screening services to Oklahoma. Leveraging the most medically advanced, state-of-the-art equipment and techniques in the industry, HealthYes! screens its clients for life-threatening medical conditions and diseases including: heart disease, stroke, abdominal aortic aneurysm, peripheral artery disease, diabetes and liver disease along with osteoporosis.
› Verified 7 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 94.7 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 91.2 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 84.2 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 89.2 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 78.9 | 97.3 |
| Patients who got timely treatment for shortness of breath | 92.3 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 62.9 | 93.3 |
News Archive
This post in KPLU's "Humanosphere" blog examines the "gap between the disease burden of mental illness and the amount of funding and attention devoted to solving the problem," referencing a post published Friday in the Global Health Interest Forum's "Blog of Scientists for Global Health," written by Paul Southworth, a visiting scholar on malaria and vaccine science at the NIH.
Frontiers is dedicating part of its open science platform infrastructure to collect and disseminate information relevant to the research communities battling the COVID-19 pandemic using its Coronavirus Knowledge Hub.
EarlySense announced today that its EverOn Touch system has been cleared for marketing by the U.S. Food and Drug Administration. The FDA clearance covers several key additions to the traditional EverOn contact-free patient supervision system value proposition. For the first time, the EverOn system includes an online display that alerts medical staff regarding a patient's motion level and verifies patient turns as indicated by nurses. Identifying low patient movement and then turning patients methodically are key elements in the prevention of pressure ulcers, the most costly patient safety risk in U.S. hospitals.
Akeso Medical Imaging BV, announces today the start of a clinical study with their novel imaging device for assessment of joint inflammation in patient with rheumatoid arthritis (RA). In this proof of concept study, Akeso's imaging device will be compared to other methods to assess disease status, such as the DAS-28 score, Ultrasound and in some cases MRI. The study will be performed at the University Medical Center Utrecht (UMC Utrecht) in cooperation with Regional Rheumatology Centre Eindhoven (RRC). Seventy subjects will be included; sixty RA patients with varying degrees of inflammation of the joints of hands and wrists at the time of examination and a control group of ten subjects.
HealthYes!®, a leading preventive medical screening company, is bringing its life-saving mobile screening services to Oklahoma. Leveraging the most medically advanced, state-of-the-art equipment and techniques in the industry, HealthYes! screens its clients for life-threatening medical conditions and diseases including: heart disease, stroke, abdominal aortic aneurysm, peripheral artery disease, diabetes and liver disease along with osteoporosis.
› Verified 7 days ago
| Home Health Aides | 9.5 |
| Counselors | 2.5 |
| Medical Social Workers | 1.5 |
| Registered Nurses | 3.75 |
| Other Personnel | 5.25 |
| Total Employees | 22.5 |
|---|
News Archive
This post in KPLU's "Humanosphere" blog examines the "gap between the disease burden of mental illness and the amount of funding and attention devoted to solving the problem," referencing a post published Friday in the Global Health Interest Forum's "Blog of Scientists for Global Health," written by Paul Southworth, a visiting scholar on malaria and vaccine science at the NIH.
Frontiers is dedicating part of its open science platform infrastructure to collect and disseminate information relevant to the research communities battling the COVID-19 pandemic using its Coronavirus Knowledge Hub.
EarlySense announced today that its EverOn Touch system has been cleared for marketing by the U.S. Food and Drug Administration. The FDA clearance covers several key additions to the traditional EverOn contact-free patient supervision system value proposition. For the first time, the EverOn system includes an online display that alerts medical staff regarding a patient's motion level and verifies patient turns as indicated by nurses. Identifying low patient movement and then turning patients methodically are key elements in the prevention of pressure ulcers, the most costly patient safety risk in U.S. hospitals.
Akeso Medical Imaging BV, announces today the start of a clinical study with their novel imaging device for assessment of joint inflammation in patient with rheumatoid arthritis (RA). In this proof of concept study, Akeso's imaging device will be compared to other methods to assess disease status, such as the DAS-28 score, Ultrasound and in some cases MRI. The study will be performed at the University Medical Center Utrecht (UMC Utrecht) in cooperation with Regional Rheumatology Centre Eindhoven (RRC). Seventy subjects will be included; sixty RA patients with varying degrees of inflammation of the joints of hands and wrists at the time of examination and a control group of ten subjects.
HealthYes!®, a leading preventive medical screening company, is bringing its life-saving mobile screening services to Oklahoma. Leveraging the most medically advanced, state-of-the-art equipment and techniques in the industry, HealthYes! screens its clients for life-threatening medical conditions and diseases including: heart disease, stroke, abdominal aortic aneurysm, peripheral artery disease, diabetes and liver disease along with osteoporosis.
› Verified 7 days ago
| Guardian Hospice Of Oklahoma Location: 1055 North Service Road, Calera, Oklahoma, 74730 Phone: (580) 434-6336 |